Evidence map›Paper›PMID 25879000›Full record

ArticleAdvanced biomedical research2015

Health related quality of life in irritable bowel syndrome patients, Kashan, Iran: A case control study.

Raika Jamali, Mostafa Raisi, Mohammad Matini, Alireza Moravveji, Abdollah Omidi, Jaleh Amini

Open access · goldAbstract read
In one paragraph

Article in Advanced biomedical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Raika JamaliStudents Scientific Research Center, Research Development Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mostafa RaisiDepartment of Internal Medicine, Beheshti Hospital, Kashan University of Medical Science, Kashan, Iran ; Isfahan University of Medical Sciences, Isfahan, Iran ; Poursina Hakim Research Institute, Isfahan, Iran.
Mohammad MatiniDepartment of Internal Medicine, Beheshti Hospital, Kashan University of Medical Science, Kashan, Iran.
Alireza MoravvejiDepartment of Preventive and Community Medicine, Social Determinants of Health Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Abdollah OmidiDepartment of Clinical Psychology, Kashan University of Medical Sciences, Kashan, Iran.
Jaleh AminiIsfahan University of Medical Sciences, Isfahan, Iran ; Poursina Hakim Research Institute, Isfahan, Iran.
Kashan University of Medical Sciences · IRIsfahan University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIrritable bowel syndrome has significant impacts on the quality of life (QOL) but IBS subtypes may be different in QOL. This study aimed to assess QOL in IBS subtypes and also two prevalent questionnaires applied to evaluate the QOL in IBS. MATERIALS AND

methodsIn this case-control study conducted in Kashan in 2010-2013. One hundred and eighty- eight patients with IBS with 215 of non-IBS patients were included in the baseline. Subjects divided into three subtypes based on symptoms of diarrhea-predominant (IBS-D), constipation-predominant (IBS-C) and IBS with mixed bowel habits (IBS-M) and in each subtype were 42, 62 and 84 patients, respectively. All IBS subjects completed questionnaires containing the disease-specific QOL for IBS (IBSQOL), World Health Organization QOL Assessment-BREF (WHOQOL-BREF) and IBS severity scores (IBSSS). The non-IBS subjects completed the WHOQOL-BREF only.

resultsMean scores of IBSQOL in person with subtypes of IBS-D, IBS-C and IBS-M were 74.34 ± 19.01, 76.77 ± 22.91 and 73.15 ± 26.51, respectively which was not significantly different (P value = 0.507). As well as mean scores of WHOQOL-BREF in person with subtypes of IBS-D, IBS-C and IBS-M were 81.01 ± 16.23, 88.32 ± 15.66, and 82.65 ± 16.67, respectively, which were not significantly different (P value = 0.412) but mean scores of WHOQOL-BREF in non-IBS subjects was 89.53 ± 11.71 which was significantly different from IBS subjects (P value = 0.022). Strong positive relationship between two instruments was shown (r = 0.826 when P < 0.05).

conclusionsThe WHOQOL-BREF instrument showed poorer QOL in IBS patients. The QOL was not different significantly among IBS-M, IBS-C, and IBS-D subtypes. We found that WHOQOL-BREF instrument strongly correlate with QOLIBS instrument.

Indexed as

Irritable bowel syndromeirritable bowel syndrome subtypesQOL for IBS questionnairequality of lifeWorld Health Organization quality of life Assessment-BREF questionnaire

Identifiers

PMID25879000
PMCPMC4386211
OpenAlexW2116712704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.